more_reports

The Latest Medical Devices Articles from Streetwise Reports

Clinical AI Use Surges as Revenue Climbs and Doctors Embrace New Tools

  ()
Doximity Inc. (DOCS:NYSE) reported 7% revenue growth as workflow active prescribers increased more than 30% year over year and AI Search queries climbed more than 25% quarter over quarter.
Tags: Life Sciences Tools & DiagnosticsMedical Devices

Doximity AI Tools Fuel Physician Engagement Growth Amid Healthcare Digital Shift

  ()
Doximity reports fiscal Q1 revenue of $156.6 million with strong workflow growth. See how its AI suite and 85% physician reach position the company in expanding digital health markets.
Tags: Life Sciences Tools & DiagnosticsMedical Devices

DarioHealth: Chronic Care Platform Drives Value

  ()
DarioHealth targets the booming digital health market with a multi-condition platform backed by 27 ADA studies. See pipeline growth, analyst targets, and key catalysts for investors.
Tags: Healthcare ServicesArtificial IntelligenceTechnologyMedical Devices

Four New ADA Studies Reveal Clinical Wins in Weight, Blood Sugar, and Healthcare Utilization

  ()
DarioHealth Corp. (DRIO:NASDAQ) presented four studies at the ADA Scientific Sessions reporting weight loss of up to 14.3%, fewer hospitalizations, and improved glycemic outcomes among high-risk cardiometabolic users of its digital health platform.
Tags: Healthcare ServicesArtificial IntelligenceTechnologyMedical Devices

Sernova Biotherapeutics Advances Toward Diabetes Solutions with FDA Orphan Drug Designation and Strengthened Capital Base

  ()
Sernova Biotherapeutics leverages its Cell Pouch technology and recent FDA orphan drug designation to address type 1 and type 3c diabetes amid a growing global market, supported by improved financial stability for retail investors.
Tags: Regenerative MedicineMedical DevicesLife Sciences Tools & Diagnostics

Biotech Secures Major FDA Orphan Drug Designation for Diabetes Treatment

  ()
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTC; PSH:XETRA) announces it has been granted orphan drug designation for autologous islet transplantation (AIT) for preventing diabetes following a total pancreatectomy.
Tags: Regenerative MedicineMedical DevicesLife Sciences Tools & Diagnostics

Canadian Biotech Co. Appoints Elite Regulatory Expert for Chile Expansion

  ()
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) appoints Chilean policy leader Felipe Leyton for the mining rollout of its AI impairment detection tech.
Tags: Medical DevicesBiotechnology / PharmaceuticalsLife Sciences Tools & Diagnostics

The World's First AI Voice Detection For Drugs & Alcohol With Charts That Beckon Investors To Buy

Contributed Technical Analyst Opinion
  ()
Technical Analyst Stewart Thomson explains why he thinks MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) is a Speculative Buy.
Tags: Medical DevicesLife Sciences Tools & Diagnostics

Bothell, WA Bio Co. Poised for 17-20% Revenue Growth in 2026 as Cell Therapy Market Expands

Research Report
  ()
BioLife Solutions Inc. (BLFS:NASDAQ) reported strong 2025 results. The company is now a pure-play cell processing business, expecting double-digit growth driven by expanding cell and gene therapy adoption, according to an H.C. Wainwright & Co. research note.
Tags: Medical DevicesBiotechnology / Pharmaceuticals

Medical Co.'s TULSA-PRO Installed Base Growth and CAPTAIN Trial Data Could Accelerate Adoption in 2026"

Research Report
  ()
Leede Financial maintained its rating on Profound Medical Corp. (PROF:NASDAQ; PRN:TSX), citing strong TULSA-PRO capital sales, expanding installed base, and upcoming CAPTAIN trial results at EAU meeting as key catalysts.
Tags: Medical Devices

Showing Results: 1 to 10 of 10